Earl M. Douglas

Former Vice President and General Counsel at BioMimetic Therapeutics

Are you Earl M. Douglas? Claim your profile
 
  • IDENTIFY corporate executives in Earl M. Douglas's network and community.
  • FOLLOW changes in Earl M. Douglas's employment and money-in-motion.
  • CONNECT with Earl M. Douglas through your network of contacts.

Earl M. Douglas's Executive Work History


Past
To view Earl M. Douglas's complete executive work history,
Education
Age
54
 

Earl M. Douglas's Biography


Earl M. Douglas, Esq. (48) Mr. Douglas joined BioMimetic in May 2005 as its Vice President and General Counsel. Mr. Douglas has been a practicing attorney for approximately 25 years, and has a strong background in intellectual property law. From January 2003 to April 2005, Mr. Douglas was self-employed as a legal consultant and completed projects for Smith & Nephew, Inc. and InterWest Partners, LP. Mr. Douglas served as Vice President and General Counsel of Spinal Dynamics Corporation (which was acquired by Medtronic, Inc.) from December 2001 to December 2002 and as Chief Patent Counsel from October 2000 to December 2001. Mr. Douglas was an ...

(Read More)

Source: BioMimetic Therapeutics on 05/09/2011

 
 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Earl M. Douglas. More specifically, you'll be able to:

  • IDENTIFY corporate executives in Earl M. Douglas's network and community.
  • FOLLOW changes in Earl M. Douglas's employment and money-in-motion.
  • CONNECT with Earl M. Douglas through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: Earl M. Douglas

Earl M. Douglas's Connections (17)


Former Chairman of the Board, OraSure Technologies, Inc.
Former Chief Financial Officer, AGTC
Former Chief Scientific Officer and Vice President, BioMimetic Therapeutics
Former Senior Vice President, Finance and Administration, and Chief Financial Officer, Immunicon Corp.
Former Senior Vice President, BioMimetic Therapeutics
Former Chief Operating Officer and Executive Vice President, BioMimetic Therapeutics